2Faught E.Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience.Epilepsia, 1997, 38(Supple 1): S24-S27. 被引量：1
3Ben-Menachem E.Clinical Efficacy of topiramate as add-on therapy in refractory partial epilepsy: The European experience.Epilepsia, 1997, 38(Supple 1): S28-S30. 被引量：1
4Reife RA, Pledger GW.Topiramate as adjunctive therapy in refractory partial Epilepsy: pooled analysis of data from five double-blind, placebo-controlled trials.Epilepsia, 1997, 38(Supple 1): S31-S33. 被引量：1
5Rosenfeld WE, Sachdeo RC, Faught RE, et al.Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment.Epilepsia, 1997, 38(Supple 1):S34-S36. 被引量：1
6Biton V.Preliminary open-lable experience with topiramate in primary generalized seizures.Epilepsia, 1997, 38(Supple 1): S42-S44. 被引量：1
7Glauser TA, Cincinnati OH, Sachdeo RC, et al.Topiramate in Lennox-Gastaut syndrome, a double blind trial.Neurology,1997,48:1729. 被引量：1
8Gram L. Pharmacokinetics of new antiepileptic drugs.Epilepsia, 1996, 37(Supple 6): S12-S16. 被引量：1
9Shorvon S, Stefan H.Overview of the safety of newer antiepileptic drugs.Epilepsia, 1997, 38(Supple 1): S45-S51. 被引量：1
10Coulter DA, Sombati S, DeLorenzo RJ.Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons.Epilepsia, 1993, 34(Suppl 2): 123. 被引量：1
